ХАТТНЕР Кеннет М. (US),КИРБИ Нил (US),ШНАЙДЕР Паскаль (CH),ГАЙДЕ Оливье (CH)
申请号：
RU2015117995
公开号：
RU2015117995A
申请日:
2013.11.13
申请国别(地区):
RU
年份:
2017
代理人:
摘要：
The invention relates to pharmaceutical compositions and methods for the treatment of ectodermal displasias via the administration of EDA agonists, in particular EDI200. Use of the compositions and methods described allow for therapeutic dosing and administration regimens in human patients to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED.
